Chase

148 Posts

Virginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access

A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS).
Read More

Health Care Financing to Improve Availability of Affordable Contraception: Identifying Promising Practices

Effective family planning that meets an individual’s needs, values, and preferences is a critical element of high-quality health care for women. Despite the well-documented role of family planning in improving maternal and infant health outcomes, persistent financial obstacles create barriers to care for many women. An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will review programs that aim to improve availability and affordability of contraception and identify effective strategies to inform future policy and practice.
Read More

In wide-ranging amicus briefs, experts again urge the Fifth Circuit to reject restrictions on telehealth access to mifepristone

Ahead of oral argument in Louisiana v. U.S. Food and Drug Administration (FDA) on September 9, a wide range of experts — including the American College of Obstetricians and Gynecologists, American College of Emergency Physicians, the National Domestic Violence Hotline, the Disability Rights Education & Defense Fund, the NAACP Legal Defense & Educational Fund, pharmaceutical and biotech manufacturers, and former military officials — are urging the U.S. Court of Appeals for the Fifth Circuit to reject anti-abortion politicians’ effort to end telemedicine and mail and pharmacy access to mifepristone nationwide.Mifepristone is used in nearly two-thirds of U.S. abortions, with more than 1 in 4 patients
Read More

Reproductive Freedom for All Launches Ad in Pennsylvania Highlighting FDA Nominee Heidi Overton’s Anti-Abortion Extremism

Reproductive Freedom for All launched a new digital ad in Pennsylvania, “Victory“, highlighting the anti-abortion extremism of Heidi Overton, Donald Trump’s nominee to lead the Food and Drug Administration. Overton has pushed disinformation about the safety of medication abortion and argued for remaking federal health agencies around Republicans’ anti-abortion agenda. If confirmed, she would run an agency that could entirely curb access to mifepristone—in effect pushing a backdoor abortion ban that is deeply unpopular with voters.
Read More

Reproductive Freedom for All Condemns Trump DOJ for Rewarding Convicted Anti-Abortion Extremist With Seven-Figure Payout Using Taxpayer Money

Trump’s administration is handing a seven-figure, taxpayer-funded settlement to a convicted anti-abortion extremist who prevented patients from accessing reproductive healthcare. Paul Vaughn was convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act after helping blockade a Tennessee clinic. This hefty payout is an alarming escalation after President Trump pardoned Vaughn and 22 other anti-abortion extremists convicted under the FACE Act just days into his second term.
Read More

Federal Court Rules FDA Abortion Pill Restrictions Are Unjustified

A federal court in Virginia ruled that the Food and Drug Administration’s (FDA) restrictions on the abortion pill mifepristone are unjustified and baseless, and ordered the agency to reconsider them. In its ruling, the court said the FDA disregarded the scientific record demonstrating that mifepristone could be safely prescribed without restrictive regulations. 
Read More

Aid cuts leave at least one million women and girls without vital support

The warning comes in a new report, Beyond the Breaking Point, which finds that those providing essential services to women and girls are being forced to reduce or suspend programmes just as global humanitarian needs reach historic highs. According to the latest figures, around 120 million women and girls worldwide now require humanitarian assistance and protection. Yet the local women's organizations best placed to reach them are facing severe funding shortages, despite often operating in places where international agencies cannot.
Read More

GOP officials eye restrictions on pregnant travelers

The ruling wasn’t as lopsided as many legal observers expected, but in Trump v. Barbara, the U.S. Supreme Court rejected the idea that a president can override the 14th Amendment to the Constitution with an executive order. Although the 5-4 ruling left in place a status quo that had existed for generations, much of the right did not respond well to the news … Republican Rep. Andy Ogles of Tennessee said Tuesday he’s moving forward with plans for legislation that he’s calling the Anchors Away Act, which would ban certain pregnant foreign women from entering the United States.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.